related documents EFFECTS OF ITRACONAZOLE ON THE PHARMACOKINETICS OF COPANLISIB, A NOVEL PAN-CLASS I PHOSPHATIDYLINOSITOL-3-KINASE INHIBITOR IN CANCER SUBJECTS. Conferences